Cipla Ltd.
10
2
2
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
60%
6 trials in Phase 3/4
13%
1 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV
Role: collaborator
A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India
Role: collaborator
BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma
Role: lead
Simplified Isoniazid Preventive Therapy Strategy to Reduce TB Burden
Role: collaborator
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
Role: collaborator
BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient
Role: lead
BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients
Role: lead
Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma
Role: lead
Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis
Role: collaborator
Prevention of Postpartum Haemorrhage With Sublingual Misoprostol or Oxytocin
Role: collaborator
All 10 trials loaded